Dallas,, TX -- (SBWIRE) -- 08/04/2011 -- The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis in this report, as researchers work to improve drug properties through drug design and molecular modeling. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry.

This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics takes a look at this aspect of the pharmaceutical marketplace with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.

The needle-free drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and reports current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:

• Needle-Free Products Market (Including Drug and Technology)
• Needle-Free Products Market (Technology Only)

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. The report also includes information that will be of assistance to business planners:
• Trends in the Vaccine Market
• Market Size and Forecast for Needle-Free Vaccine Technology
• Trends in Biopharmaceuticals
• Leading Pharmaceutical Product Sold With Needle-Free Technologies
• Products in Development
• Detailed Profiles of Key Companies in Needle-Free Technologies.
• Current Market Size and Forecasts to 2013
• Needle-Free Cost Savings, Autojets, Health Care Reform, and Other Trends and Developments

Companies Profiled in the report include:
• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• Pacira Pharmaceuticals, Inc.
• pSivida
• SurModics, Inc
• Zogenix Corporation
• AP Pharma
• Baxter BioPharma Solutions
• QLT USA, Inc
• Ypsomed Holding AG

The research conducted by Kalorama included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person, email and telephone interviews were the primary method of gathering information.

http://www.reportsnreports.com/reports/117995-needle-free-drug-delivery-the-market-for-alternatives-to-needle-.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/